This compounded formulation consists of Fluticasone Propionate 3 mg, Levocetirizine Dihydrochloride 2 mg, and Montelukast 3 mg in a single capsule. The capsule's contents are intended to be mixed with saline for nasal irrigation or nebulization.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a meticulously compounded formulation of Fluticasone Propionate 3 mg, Levocetirizine Dihydrochloride 2 mg, and Montelukast 3 mg in a solid dosage form. This unique formulation is specifically designed for use in nasal irrigation or nebulization, providing targeted treatment for a variety of respiratory conditions such as Asthma, Allergic Rhinitis, Chronic Obstructive Pulmonary Disease, Bronchitis, and Sinusitis.
Each capsule is intended to be emptied and mixed with a saline solution for irrigation or nebulization as directed. This method of administration ensures that the active ingredients are delivered directly to the affected areas, providing targeted relief from symptoms. The three active ingredients in this formulation work in harmony to alleviate the symptoms associated with these respiratory conditions.
Fluticasone Propionate is a potent corticosteroid that works by reducing inflammation in the airways, thereby helping to alleviate symptoms such as wheezing, shortness of breath, and chest tightness. Levocetirizine Dihydrochloride, an antihistamine, aids in reducing allergy symptoms such as runny nose, sneezing, itchy or watery eyes, and itching of the nose or throat. Montelukast, a leukotriene receptor antagonist, further assists in reducing inflammation in the airways, facilitating easier breathing and reducing the frequency of asthma attacks.
This compounded formulation is a testament to our commitment to providing innovative solutions for managing respiratory health. If you have any queries about this formulation, its application, or how it may benefit you, please feel free to contact our team of experienced compounding pharmacists at Bayview Pharmacy. We are dedicated to providing you with the information and support you need to effectively manage your respiratory health.
Fluticasone Propionate 3 mg/Levocetirizine Dihydrochloride 2 mg/Montelukast 3 mg Capsules are a specially compounded medication designed to address a variety of respiratory conditions. These conditions include Asthma, Allergic Rhinitis, Chronic Obstructive Pulmonary Disease (COPD), Bronchitis, and Sinusitis. The unique blend of these three active ingredients works in harmony to alleviate inflammation and enhance breathing capabilities.
Fluticasone Propionate is a potent corticosteroid that effectively mitigates inflammation within the airways, thereby relieving symptoms associated with respiratory conditions. Levocetirizine Dihydrochloride, a powerful antihistamine, assists in curbing the body’s allergic response, which in turn minimizes allergy symptoms that can worsen respiratory conditions. Montelukast, a leukotriene receptor antagonist, further contributes to reducing inflammation in the airways, enhancing the overall effectiveness of this compounded medication.
It's important to note that these capsules are not designed for oral intake. They are specifically formulated to be emptied and combined with a saline solution for nasal irrigation or nebulization. This method of administration ensures that the medication is delivered directly to the affected areas, providing targeted treatment. This formulation is typically used in conjunction with the NeilMed™ Sinus Rinse system for nasal irrigation.
As with all medications, it is essential to use this formulation as directed by your healthcare provider. If you have any queries or concerns about the usage of this medication, or if you experience any adverse effects, it is crucial to reach out to your healthcare provider or pharmacist for advice. At Bayview Pharmacy, we are dedicated to providing comprehensive information and support to ensure the safe and appropriate use of our compounded medications.
Fluticasone Propionate 3 mg/Levocetirizine Dihydrochloride 2 mg/Montelukast 3 mg Capsules are a compounded medication specifically designed to treat a range of respiratory conditions. These include asthma, allergic rhinitis, chronic obstructive pulmonary disease (COPD), bronchitis, and sinusitis. The unique formulation of this medication aims to alleviate inflammation and swelling in the airways, thereby facilitating easier breathing.
The medication operates by inhibiting the action of certain chemicals in the body that trigger inflammation and swelling. Additionally, it aids in reducing mucus production, which can help alleviate congestion and enhance breathing. The synergistic effect of these three medications helps to mitigate inflammation and swelling in the airways, thereby promoting easier breathing.
This medication is available in a capsule form. The contents of each capsule are intended to be emptied and mixed with a saline solution for nasal irrigation or nebulization as directed. This method allows for targeted administration of the medication, ensuring that the active ingredients reach the affected areas directly. This medication is typically used with the NeilMed™ Sinus Rinse for nasal irrigation.
It is crucial to adhere to the instructions provided by your healthcare provider when using this medication. If you have any queries or concerns about how to use this medication, it is recommended to consult with your healthcare provider or pharmacist. Remember, proper usage ensures the effectiveness of the medication and minimizes potential side effects.
Fluticasone Propionate 3 mg/Levocetirizine Dihydrochloride 2 mg/Montelukast 3 mg Capsules are a compounded medication designed for targeted treatment of conditions such as Allergic Rhinitis, Sinusitis, Rhinitis of Pregnancy, Nasal Polyps, and Chronic Rhinosinusitis. The contents of each capsule are intended to be mixed with a saline solution for irrigation or nebulization, allowing for direct administration to the nasal passages.
This formulation works by reducing inflammation in the nasal passages, which can alleviate symptoms such as nasal congestion, sneezing, and itching. It also helps to decrease the production of mucus in the nasal passages, which can lower the risk of sinus infections. Furthermore, this formulation can help to lessen the severity of asthma symptoms, including wheezing, coughing, and shortness of breath.
Additionally, Fluticasone Propionate 3 mg/Levocetirizine Dihydrochloride 2 mg/Montelukast 3 mg Capsules can be used to mitigate the risk of complications arising from allergic rhinitis, such as sinus infections, ear infections, and exacerbations of asthma. It can also help to reduce the risk of complications associated with rhinitis of pregnancy, including preterm labor and low birth weight.
If you have any questions about this formulation or its uses, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your healthcare needs.
This compounded formulation is designed to provide targeted administration of these medications for nasal irrigation or nebulization. It is typically used to manage symptoms of allergies, asthma, and other respiratory conditions.
The contents of one capsule are intended to be emptied and mixed with a saline solution. This mixture is then used for irrigation or nebulization as directed by your healthcare provider.
No, these capsules are not intended for oral consumption. They are designed to be mixed with a saline solution for nasal irrigation or nebulization.
Each capsule contains 3 mg of Fluticasone Propionate, 2 mg of Levocetirizine Dihydrochloride, and 3 mg of Montelukast.
Fluticasone Propionate is a corticosteroid that reduces inflammation, Levocetirizine Dihydrochloride is an antihistamine that relieves allergy symptoms, and Montelukast is a leukotriene receptor antagonist that helps to reduce asthma symptoms and prevent asthma attacks.
No, the dosage should be determined by your healthcare provider. Do not adjust the dosage without consulting your healthcare provider.
If you miss a dose, use it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Side effects may include nasal irritation, nosebleeds, and changes in taste or smell. If any of these effects persist or worsen, notify your healthcare provider promptly.
Consult your healthcare provider before using this medication if you are pregnant or breastfeeding. The effects on the fetus or infant are not fully known.
Before starting any new medication, including over-the-counter drugs and dietary supplements, discuss with your healthcare provider to ensure there are no potential interactions.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Empty contents of 1 capsule and mix with saline solution and irrigate/nebulize